![]() |
Volumn 45, Issue 1, 2002, Pages 1-18
|
Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 OXOHEXAHYDROPYRROLO[3,2 B]PYRROLE DERIVATIVE;
ACETYLCHOLINESTERASE;
ELASTASE;
PROTEINASE;
PROTEINASE INHIBITOR;
PYRROLIDINE 5,5 LACTAM DERIVATIVE;
THROMBIN;
UNCLASSIFIED DRUG;
VIRUS ENZYME;
ARTICLE;
CHIRALITY;
CONCENTRATION RESPONSE;
DRUG DESIGN;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVE SITE;
ENZYME INHIBITOR INTERACTION;
HUMAN CYTOMEGALOVIRUS;
MOLECULAR DYNAMICS;
STRUCTURE ACTIVITY RELATION;
ANTIVIRAL AGENTS;
BINDING SITES;
CRYSTALLOGRAPHY, X-RAY;
CYTOMEGALOVIRUS;
LACTAMS;
MASS SPECTROMETRY;
MODELS, MOLECULAR;
PROTEASE INHIBITORS;
PYRROLES;
SERINE ENDOPEPTIDASES;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0037011893
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm0102203 Document Type: Article |
Times cited : (69)
|
References (21)
|